Literature DB >> 2942026

Percutaneous transluminal balloon pulmonary valvuloplasty for the relief of pulmonary valve stenosis with special reference to double-balloon technique.

M A Ali Khan, S A Yousef, C E Mullins.   

Abstract

PTBPV was performed 33 times in 32 patients in the Riyadh Armed Forces Hospital. Patients ranged in age from 6 months to 12 years (mean 4.5 years); average weight was 14.86 kg. Before dilatation, all patients had grade 4/6 late peaking systolic ejection murmurs, with right-axis deviation and right ventricular hypertrophy on ECG. Moderate to severe pulmonary valve stenosis (right ventricle-pulmonary artery gradient 50 mm Hg systolic) was confirmed both hemodynamically and angiographically. Balloon size was selected to be approximately 2 mm larger than the pulmonary valve anulus was over 25 were inflated to approximately 5 atmospheres of pressure. Two patients required two simultaneous balloons as the pulmonary valve anulus was over 25 mm. Predilatation peak systolic pressure gradients ranged from 50 to 245 mm Hg (mean 99.2 mm Hg); postdilatation gradients ranged from 8 to 93 mm Hg (mean 23.4 mm Hg). There were no deaths or complications. The systolic murmur with early systolic peak decreased in all but three patients. Systolic thrill disappeared in all but three patients. Follow-up at an average of 10 months revealed increasing exercise tolerance in two thirds of patients. Fourteen patients have been recatheterized at least 6 months after dilatation and showed persistent minimal gradient. We conclude that balloon valvuloplasty of pulmonary valve stenosis is an effective, safe procedure. At this writing, a total of 90 successful PTBPVs have been performed, with equally impressive results.

Entities:  

Mesh:

Year:  1986        PMID: 2942026     DOI: 10.1016/0002-8703(86)90695-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  The development of a pseudo-chamber after balloon pulmonary angioplasty: long-term complications of balloon pulmonary angioplasty.

Authors:  Hisashi Sugiyama; Hiroaki Kise; Takako Toda; Minako Hoshiai
Journal:  Heart Vessels       Date:  2016-04-30       Impact factor: 2.037

2.  Balloon dilatation of stenotic lesions of the heart.

Authors:  S Shrivastava
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

3.  Angiographic features associated with percutaneous balloon valvotomy for pulmonary valve stenosis.

Authors:  P E Burrows; L N Benson; J S Smallhorn; C A Moes; R M Freedom; F A Burrows; R D Rowe
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

4.  Dual-balloon angioplasty of recoarctation of the aorta.

Authors:  J W Moore; C E Pearson; Da H Lee; B Raybuck
Journal:  Tex Heart Inst J       Date:  1987-03

5.  [Cardiocirculatory failure--new therapeutic possibilities].

Authors:  E Erdmann
Journal:  Langenbecks Arch Chir       Date:  1987

6.  Balloon dilatation of critical stenosis of the pulmonary valve in neonates.

Authors:  E J Ladusans; S A Qureshi; J M Parsons; S Arab; E J Baker; M Tynan
Journal:  Br Heart J       Date:  1990-06

7.  Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.

Authors:  Jinar Rostami; Tobias Mothes; Mahshad Kolahdouzan; Olle Eriksson; Mohsen Moslem; Joakim Bergström; Martin Ingelsson; Paul O'Callaghan; Luke M Healy; Anna Falk; Anna Erlandsson
Journal:  J Neuroinflammation       Date:  2021-06-03       Impact factor: 8.322

Review 8.  Therapeutic Utilities of Pediatric Cardiac Catheterization.

Authors:  Giannis A Moustafa; Argyrios Kolokythas; Konstantinos Charitakis; Dimitrios V Avgerinos
Journal:  Curr Cardiol Rev       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.